Cargando…

An analysis of the effect of mu-opioid receptor gene (OPRM1) promoter region DNA methylation on the response of naltrexone treatment of alcohol dependence

This study explored the effect of OPRM1 promoter region DNA methylation on the outcome of treatment with the opioid antagonist naltrexone (NTX) for alcohol dependence (AD). Ninety-three patients with DSM-IV AD [41 African Americans (AAs) and 52 European Americans (EAs)] received double-blind treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yufei, Kranzler, Henry R., Farrer, Lindsay A., Xu, Hongqin, Henderson, David C., Zhang, Huiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415483/ https://www.ncbi.nlm.nih.gov/pubmed/32029903 http://dx.doi.org/10.1038/s41397-020-0158-1

Ejemplares similares

Alcohol and nicotine codependence-associated DNA methylation changes in promoter regions of addiction-related genes
por: Xu, Hongqin, et al.
Publicado: (2017)

Haplotype block structure of the genomic region of the mu opioid receptor gene (OPRM1)
por: Levran, Orna, et al.
Publicado: (2010)

Anhedonia to music and mu-opioids: Evidence from the administration of naltrexone
por: Mallik, Adiel, et al.
Publicado: (2017)

Alternative Pre-mRNA Splicing of the Mu Opioid Receptor Gene, OPRM1: Insight into Complex Mu Opioid Actions
por: Liu, Shan, et al.
Publicado: (2021)

Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent
por: AL-Eitan, Laith N, et al.
Publicado: (2012)

Variation of the human mu-opioid receptor (OPRM1) gene predicts vulnerability to frustration
por: Daniel, Alan M., et al.
Publicado: (2020)

Placental OPRM1 DNA methylation and associations with neonatal opioid withdrawal syndrome, a pilot study
por: Wachman, Elisha M., et al.
Publicado: (2020)

Association of opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with nicotine dependence
por: Kong, Xiangyi, et al.
Publicado: (2017)

Effect of short-term prescription opioids on DNA methylation of the OPRM1 promoter
por: Sandoval-Sierra, Jose Vladimir, et al.
Publicado: (2020)

Characterizing exons 11 and 1 promoters of the mu opioid receptor (Oprm) gene in transgenic mice
por: Xu, Jin, et al.
Publicado: (2006)

Functional Polymorphism of the Mu-Opioid Receptor Gene (OPRM1) Influences Reinforcement Learning in Humans
por: Lee, Mary R., et al.
Publicado: (2011)

Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta-analysis
por: Coller, Janet K, et al.
Publicado: (2009)

Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype
por: Ziauddeen, Hisham, et al.
Publicado: (2016)

Naltrexone and the Treatment of Alcohol Dependence
por: Volpicelli, Joseph R., et al.
Publicado: (1994)

Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians
por: Ehlers, Cindy L, et al.
Publicado: (2008)

Whose mu fared better? The effect of extended-release naltrexone (XR-NTX) on treatment outcomes for opioid and alcohol users
por: Crèvecoeur-MacPhail, Desirée A
Publicado: (2015)

Characterizing OPRM1 DNA methylation in prescription opioid users with chronic musculoskeletal pain
por: Sheikh, Sophia, et al.
Publicado: (2022)

DNA methylation at the mu-1 opioid receptor gene (OPRM1) promoter predicts preoperative, acute, and chronic postsurgical pain after spine fusion
por: Chidambaran, Vidya, et al.
Publicado: (2017)

Ethanol/Naltrexone Interactions at the mu-Opioid Receptor. CLSM/FCS Study in Live Cells
por: Vukojević, Vladana, et al.
Publicado: (2008)

Naltrexone is neuroprotective against traumatic brain injury in mu opioid receptor knockout mice
por: Wang, Yu‐Syuan, et al.
Publicado: (2021)

Lack of associations of the opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with alcohol dependence: review and meta-analysis of retrospective controlled studies
por: Kong, Xiangyi, et al.
Publicado: (2017)

A polymorphism in the OPRM1 3′ untranslated region is associated with methadone efficacy in treating opioid dependence
por: Crist, Richard C., et al.
Publicado: (2016)

Advancing Precision Medicine for Alcohol Use Disorder: Replication and Extension of Reward Drinking as a Predictor of Naltrexone Response
por: Witkiewitz, Katie, et al.
Publicado: (2019)

Variation in the Mu-Opioid Receptor (OPRM1) and Offspring Sex Are Associated With Maternal Behavior in Rhesus Macaques (Macaca mulatta)
por: Wood, Elizabeth K., et al.
Publicado: (2022)

Pharmacological enhancement of naltrexone treatment for opioid dependence: a review
por: Mannelli, Paolo, et al.
Publicado: (2011)

Long-Acting Injectable Naltrexone for the Management of Patients with Opioid Dependence
por: Kjome, Kimberly L., et al.
Publicado: (2011)

Identification and characterization of seven new exon 11-associated splice variants of the rat mu opioid receptor gene, OPRM1
por: Xu, Jin, et al.
Publicado: (2011)

Profiling of Childhood Adversity-Associated DNA Methylation Changes in Alcoholic Patients and Healthy Controls
por: Zhang, Huiping, et al.
Publicado: (2013)

µ-Opioid Receptor Gene (OPRM1) Polymorphism A118G: Lack of Association in Finnish Populations with Alcohol Dependence or Alcohol Consumption
por: Rouvinen-Lagerström, Noora, et al.
Publicado: (2013)

Naltrexone Implant for Opioid Use Disorder
por: Edinoff, Amber N., et al.
Publicado: (2021)

Naltrexone blocks alcohol-induced effects on kappa-opioid receptors in the plasma membrane
por: Terenius, Lars, et al.
Publicado: (2023)

Naltrexone long-acting formulation in the treatment of alcohol dependence
por: Johnson, Bankole A
Publicado: (2007)

Thermosensitive biomaterial gels with chemical permeation enhancers for enhanced microneedle delivery of naltrexone for managing opioid and alcohol dependency
por: Tobin, Kevin V., et al.
Publicado: (2023)

Use of methyl-naltrexone for the treatment of opioid-induced constipation in critical care patients
por: Sawh, SB, et al.
Publicado: (2010)

Exploring Pharmacological Functions of Alternatively Spliced Variants of the Mu Opioid Receptor Gene, Oprm1, via Gene-Targeted Animal Models
por: Kang, Wenjian, et al.
Publicado: (2022)

Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of OPRM1 A/G Polymorphism on Its Effectiveness
por: Verholleman, Audrey, et al.
Publicado: (2020)

Region Specific Up-Regulation of Oxytocin Receptors in the Opioid Oprm1(−/−) Mouse Model of Autism
por: Gigliucci, Valentina, et al.
Publicado: (2014)

Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond
por: Gaddis, Nathan, et al.
Publicado: (2022)

Genomewide Study of Epigenetic Biomarkers of Opioid Dependence in European- American Women
por: Montalvo-Ortiz, Janitza L., et al.
Publicado: (2019)

Naltrexone ameliorates functional network abnormalities in alcohol‐dependent individuals
por: Morris, Laurel S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fpe9sff2v218cq1roil941aalq